Patents by Inventor Mathieu H. M. Noteborn

Mathieu H. M. Noteborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Determining the transforming capability of agents
    Patent number: 6528247
    Abstract: The invention related to activation of apoptin-induced apoptosis by different cell-transforming agents in normal and or cancer-prone cells. Apoptin, also called VP3, is a viral protein derived from the Chicken anemia virus. Also the invention related to preventive anti-tumor therapies of normal and/or cancer-prone cells. Treatment of normal and/or cancer prone cells with tumor-inducing agents will activate apoptin-induced apoptosis, resulting in the elimination of potential tumor cells. Also the invention relates to diagnosis of cancer agents. Agents with tumor activity can be examined by expressing them in normal cells and analyzing their capability of enabling apoptin-induced apoptosis.
    Type: Grant
    Filed: May 2, 2000
    Date of Patent: March 4, 2003
    Assignee: Leadd B.V.
    Inventor: Mathieu H. M. Noteborn
  • CLONING OF CHICKEN ANEMIA DNA
    Publication number: 20020103336
    Abstract: Recombinant genetic information (DNA or RNA), comprising a Chicken Anemia Virus (CAV)-specific nucleotide sequence and the use thereof for diagnostics, vaccination or protein production. Recombinant CAV protein and the use thereof for diagnostics, vaccination or production of CAV-specific antibodies. The use of CAV-specific antibodies thus obtained.
    Type: Application
    Filed: August 27, 1999
    Publication date: August 1, 2002
    Inventors: MATHIEU H. M. NOTEBORN, GERBEN F. DE BOER